Background: Neoadjuvant concurrent chemoradiotherapy (nCCRT) is one of the standard-of-care options for locally advanced esophageal squamous cell carcinoma (LA-ESqCC). The optimal interval between nCCRT and esophagectomy is unknown. Methods: We constructed a propensity-score-matched [1:1 for long (8-12 weeks) vs short (4-7 weeks) intervals] cohort of LA-ESqCC patients who were diagnosed from 2011 to 2015 and treated with nCCRT via the Taiwan Cancer Registry and related databases. We compared the hazard ratios (HRs) of death using a robust variance estimator. We also evaluated alternative covariables, outcomes, and interval definitions. Results: Our study population included 80 patients for each group; groups were balanced with respect to the observed covariables. There was no significant difference for the HR of death [1.22; 95% confidence interval 0.78-1.91, P = 0.39] when the long interval group was compared to the short interval group. There were also no significant differences when alternative covariables, outcomes, or interval definitions were evaluated. Conclusions: In this population-based study in modern Asia, we found that for LA-ESqCC patients treated with nCCRT and esophagectomy, overall survival was similar for either long or short intervals between nCCRT and esophagectomy. Randomized controlled trials are needed to verify this finding.
Background
Esophageal cancer is one of the common causes of cancer mortality worldwide [1] . In contrast to the Western world, where adenocarcinoma is the common histology, squamous cell carcinoma (SqCC) is the predominant histology in Asia [2] . For locally advanced esophageal SqCC (LA-ESqCC), neoadjuvant concurrent chemoradiotherapy (nCCRT) is one of the standard-of-care options [3] [4] [5] [6] .
However, the optimal interval between nCCRT and esophagectomy is debated in the literature [7] . In clinical practice, some interval is needed for patients to recover from the side effects of nCCRT, but delayed surgery might lead to tumor growth. In the experience of nCCRT for rectal cancer, a randomized controlled trial (RCT) reported that prolongation was associated with a higher pathological complete response (pCR) [8] , a wellknown good prognostic factor [9] . In contrast, another RCT reported that prolongation led to a similar pCR but a higher morbidity [10] .
Regarding nCCRT for esophageal cancer, a systematic review of non-RCTs published in 2018 reported that a long interval (> 7-8 weeks, vs ≤ 7-8 weeks) was associated with higher pCR rates but worse overall survival (OS), both with statistical significance [7] . However, all Asian studies included in this study were based on patients treated almost a decade ago. In addition, the results of individual studies included in this systematic review were variable. Given the abovementioned geographic variation, controversy in this topic, and lack of RCTs, we aimed to compare the OS of LA-ESqCC treated with nCCRT and esophagectomy in modern Asia with either long or short intervals via a population-based propensity-score-matched analysis.
Methods

Data source
The Health and Welfare Data Science Center (HWDC), Ministry of Health and Welfare, database is a set of databases providing complete information regarding the Taiwan Cancer Registry (TCR) (data until 2015), the death registry (data until December 31, 2017), and reimbursement data from the National Health Insurance (NHI) (data until December 31, 2016) for the whole Taiwan population, and it is provided by the Bureau of National Health Insurance [11] . The quality of the TCR was reported in 2019 [12] . The NHI research database has also been used in many population-based studies. All of the HWDC data with personal information were deidentified.
Study population and design
The study flow chart, as suggested in the STROBE statement [13] , is depicted in Fig. 1 . In this retrospective cohort study, we used the HWDC database to identify LA-ESqCC patients who were diagnosed from 2011 to 2015 and treated with nCCRT (radiotherapy 40-50.4 Gy at a dose per fraction of 1.8-2 Gy) and esophagectomy. nCCRT was defined as concurrent systemic and locoregional therapy with preoperative radiotherapy per the TCR record. Patients with other cancer(s) were excluded. The date of diagnosis was used as the index date. We determined the explanatory variable of interest [interval between nCCRT and esophagectomy (long interval (8-12 weeks) vs short interval (4-7 weeks))] based on the cancer registry data; the primary outcome of interest [OS] and other supplementary outcomes [pCR, 30 and 90 day mortality (since surgery), incidence of local regional recurrence (ILRR), and esophageal cancer mortality (IECM)] were extracted from the TCR or determined via linkage with the death registry. OS was calculated from the date of diagnosis to the date of death or December 31, 2017 (censoring date of the death registry). We also considered other covariables [see the next section] to adjust for potential nonrandomized treatment selection and then constructed a propensity-score (PS)matched sample (1:1 paired matching) to evaluate the effectiveness of the interval between nCCRT and esophagectomy.
Other explanatory covariables
We 
Statistical analyses
In the primary analysis (PA), we used the propensity score method as advocated in the literature to balance the measured potential confounders [14, 15] . We used a logistic regression model based on all covariables [see the above subsection "Other explanatory covariables"] to evaluate the probability with a long interval [vs a short interval]. Patients were matched on the logit of the propensity score using a caliper of 0.25 standard deviations of the logit of the propensity score via a greedy match algorithm as used in the literature [16] . The standardized difference (SDif) was used to assess the balance of the covariates [17, 18] . We used a robust variance estimator to compare the hazard ratio (HR) of death between PSmatched groups during the entire follow-up period [15] and evaluated the effect of potential unmeasured confounding factor(s) via the E value [19] . Binary outcomes (pCR) within the matched pairs were compared using McNemar's test. We adopted the subdistribution HR via Institute, Cary, NC, USA) was used for statistical analyses.
Results
Study population
As shown in Fig. 1 , we identified 160 eligible PSmatched patients treated with nCCRT and esophagectomy between 2011 and 2015 from 7908 esophageal cancer patients (65% locally advanced) as our primary study population and divided them into two groups [long interval group (n = 80) vs short interval group (n = 80)]. All covariates were balanced [SDif < 0.25] after matching (Table 1) , though some were not balanced before matching.
Primary analysis
After a median follow-up of 30 months [range 4-81] (median 41 and range 24-81 for the survivors), 83 deaths were recorded (39 and 44 in the short and long interval groups, respectively). The Kaplan-Meier OS curve is shown in Fig. 2 The results of the HR for ILRR (HR = 1.44, P = 0.29) and IECM (HR = 1.18, P = 0.48) were similar. The pCR rates (55% vs 54% for the short vs long interval groups, P = 1), 30-day mortality (P = 0.06, exact numbers not reported per HWDC policy due to few events), and 90-day mortality (4% vs 9%, P = 0.19) were also not significantly different between the two groups.
Supplementary analysis (SA)
When alternative definitions of the interval between nCCRT and esophagectomy were used, we were still able to construct balanced study populations ( Table 2 ). The results were not significantly different [SA-1: HR for death 1.08, P = 0.71; SA-2: HR for death 1.32, P = 0.10]. In SA-3, we constructed another balanced study population ( Table 3 ) and found that the results were not significantly different [HR for death 1.22, P = 0.35]. There were also no statistically significant differences in the distribution of R0 resection [P = 0.07, exact proportion not reported per HWDC policy due to the small number of events]. In SA-4, we constructed additional balanced study population ( Table 4 ) and found that the results were not significantly different [HR for death 1.01, P = 0.98].
Discussion
In our analysis of LA-ESqCC treated with nCCRT and esophagectomy in this population-based study from modern Asia, we found that OS was similar for long and short intervals between nCCRT and esophagectomy. We searched the literature up to May 2019 by using the same strategy as used in the recent systematic review [7] to see if there were other modern studies and found two population-based studies from North America and another two single-institution studies from Asia [25] [26] [27] [28] . Azab et al. utilized the American National Cancer Database (NCDB) to identify more than 5000 patients (81% adenocarcinoma) and found that SqCC groups had similar OS across interval lengths [25] . Franko and McAvoy used the same NCDB specifically for SqCC and found that OS was not affected by the interval length [26] . Furukawa et al. identified 134 patients from a Japanese hospital and reported that OS survival rates did not significantly differ between the two groups (≤ 8 or > 8 weeks) [27] . Roh et al. identified 348 Korean patients and found no significant difference in OS between the groups [P = 0.101] [28] . Our results were similar to the results of these four studies in that the OS between different interval length groups was similar.
However, there were inherent limitations in our analysis. As in all nonrandomized studies, our results were prone to potential unmeasured confounder(s), although we used PS matching to balance observed covariables. There was a risk of unmeasured confounders (such as surgical techniques or systemic therapy details), so we reported the E value, as suggested in the literature [19] . For example, a transthoracic approach has been reported to lead to a trend of favorable long-term outcomes [29] and taxane has been used in modern neoadjuvant trials with excellent results [23] . Besides, the importance of the anastomotic sites or the surgical fields was debated in the literatures [30] . However, these factors were not considered in our study due to the data not being available. Some potential pathological factors like extranodal extension, perineural invasion, or lymphovascular invasion were also not included due to the same data limitation. Therefore, phase III RCTs are needed to clarify the findings from our study and other studies. However, when we searched the clinical trial registry [https://clinicaltrials.gov/] in March 2019 using the keywords "esophagectomy | Interventional Studies | Esophagus Cancer | Phase 3", we found no relevant studies. Therefore, we believe that our study provides useful information until higher-level data are available.
Conclusions
In this population-based study from modern Asia, we found that for LA-ESqCC patients treated with nCCRT and esophagectomy, OS was similar for long and short intervals between nCCRT and esophagectomy. Randomized controlled trials are needed to clarify this finding. 
